This means the bone is losing its minerals, like calcium. This can happen for a short time, maybe because someone is in space or not moving much. It's different from osteoporosis, which is a long-term condition where bones become weaker and more likely to break. Demineralization is also used in labs to study bone.
Every report comes from a Lived member, sent anonymously.
Have you tried Vitamin D for Pathologic Bone Demineralization?
Pathologic bone demineralization means bone is losing its minerals, mainly calcium and phosphate, beyond what normal bone renewal replaces. Those minerals are what make bone hard and strong, so bone that loses them becomes thinner or softer and more likely to break. The term describes a process rather than one specific disease, and what it means for a given person depends on the cause. It covers several different situations. Bone can lose mineral temporarily during prolonged bed rest, after a limb is immobilized in a cast, after paralysis, or during spaceflight, when the skeleton no longer carries its usual load. Osteoporosis is a long-term form in which overall bone mass falls and bone structure weakens, raising the risk of fractures, most often of the hip, spine and wrist. Osteomalacia is different again: the body cannot properly harden new bone with minerals, usually because of a severe lack of vitamin D, so bone becomes soft and painful. Most bone mineral loss causes no symptoms until a bone breaks, which is why it is often found on a scan or after a fracture.
Bone is living tissue that is constantly broken down and rebuilt. Demineralization happens when breakdown outpaces rebuilding, or when new bone cannot take up minerals properly. Loss of mechanical loading is a strong driver. Bone relies on the forces of standing, walking and muscle pull to stay dense, and long bed rest, a cast or brace, weightlessness and paralysis all remove them. After a spinal cord injury, bone loss below the level of the injury is common and progressive, and the area around the knee (the lower thigh bone and upper shin bone) is where fractures most often occur. Aging and the hormone changes after menopause are the main contributors to osteoporosis. Other recognized risk factors include a parent with osteoporosis or a hip fracture, low intake of calcium, vitamin D or protein, smoking, long-term heavy alcohol use, and conditions such as hormone (endocrine) disorders, some digestive diseases, rheumatoid arthritis, certain cancers, HIV and anorexia nervosa. Long-term use of some medicines also contributes, including corticosteroids (steroid medicines that reduce inflammation), proton pump inhibitors used for acid reflux, and some epilepsy medicines. Osteomalacia in adults mainly results from severe vitamin D deficiency. That can come from too little sunlight or dietary vitamin D, poor absorption in the intestine (as with celiac disease, Crohn's disease or after gastric bypass surgery), or liver or kidney disease that keeps the body from converting vitamin D to its active form. A risk factor raises the chance of bone loss; it does not mean it will happen.
Because bone mineral loss is usually silent, it tends to be found through a bone density scan, after a fracture, or during testing prompted by a known risk such as long-term steroid treatment or paralysis. The standard scan is DXA (dual-energy X-ray absorptiometry), a quick, low-radiation X-ray that usually measures the spine and hip. DXA results are reported mainly as a T-score, which compares your bone density with that of a young, healthy reference group. A negative number means thinner bone than that group. A T-score of -1.0 or higher is in the normal range. A score from -1.1 to -2.4 suggests low bone density, often called osteopenia, and a score of -2.5 or lower usually means osteoporosis. The more negative the number, the higher the risk of fracture. Clinicians often pair the scan with a fracture risk calculation such as FRAX, a short questionnaire that estimates the chance of breaking a bone over the next 10 years. Ordinary X-rays can show a collapsed spinal bone or the hairline cracks (pseudofractures) typical of osteomalacia, but they are not a reliable way to measure density. Blood tests help separate the causes, including calcium, phosphate, vitamin D, alkaline phosphatase (an enzyme often raised in bone disorders), parathyroid hormone and kidney function. This step matters because osteomalacia can look like osteoporosis on a density scan yet needs different treatment. Occasionally a small sample of bone (a biopsy) is taken to confirm softening.
Treatment depends on the cause, so identifying it comes first. The shared goals are to stop further loss, restore mineral where possible and prevent fractures. When immobilization or unloading is the cause, getting weight back onto the skeleton is central: standing, walking and strength exercise, built up gradually with guidance from the care team. Bone can partly recover once normal activity returns, but recovery can be slow and incomplete. In some astronauts, loss in the inner bone of the hip has persisted for up to two years after six-month missions. After a spinal cord injury, bone loss is harder to reverse. Rehabilitation such as assisted standing, walking with exoskeleton devices or electrically stimulated muscle contraction is used, but bone strength needs to be checked before loading fragile bone because the loading itself can cause a fracture. Denosumab has reduced bone loss in the early months after injury, while bisphosphonates have shown unclear benefit, and whether either prevents fractures after spinal cord injury is not yet established. Osteomalacia from vitamin D deficiency is treated by replacing what is missing, usually vitamin D, calcium and sometimes phosphorus by mouth. People who absorb nutrients poorly may need larger doses and regular blood tests. For osteoporosis, treatment combines enough calcium, vitamin D and protein, weight-bearing, strength and balance exercise, stopping smoking, limiting alcohol and preventing falls, with medicine when fracture risk is high. Bisphosphonates, taken by mouth or given by vein, are the most widely used medicines and slow the breakdown of bone. Denosumab, an injection under the skin, also slows bone breakdown, but its effect fades quickly once it is stopped, and stopping it has led to rapid bone loss and spine fractures, so any change is planned with the prescriber. Medicines that help build new bone, such as teriparatide and abaloparatide, or romosozumab for more severe thinning, are other options. If a medicine such as a corticosteroid is contributing, it is worth reviewing with the prescriber whether it is still needed.
The outlook depends largely on the cause. Mineral lost during a period of immobilization often comes back at least partly once a person is moving and bearing weight again, though this takes time and may not be complete. Osteomalacia from vitamin D deficiency usually responds well: some people feel better within a few weeks, and bone healing is expected within about six months, but it can return if the underlying cause, such as poor absorption, continues. Osteoporosis is usually long-term, and treatment aims to lower fracture risk rather than return bones to how they once were. Most people feel nothing as their bone density changes, so progress is tracked with follow-up scans, often every two years or more when checking a treatment, and with blood tests when vitamin D or calcium is involved. Day to day, the practical focus is preventing fractures: staying as active as is safe, building strength and balance, reducing fall hazards at home, and avoiding movements that strain a fragile spine, such as forceful twisting or bending forward from the waist. Spine fractures can happen with little or no injury and may cause gradual height loss or a stooped posture. For people living with paralysis or long-term immobility, bone health becomes an ongoing part of rehabilitation planning.
Ask about bone health if you have had a long period of bed rest or immobilization, a spinal cord injury, long-term corticosteroid treatment, a condition that affects nutrient absorption, or a parent with osteoporosis or a hip fracture. Women aged 65 and older are generally advised to have a bone density test at least once. A bone that breaks from a minor fall or ordinary activity is a reason to ask specifically whether bone loss is involved. Contact your care team soon about new or worsening back pain, noticeable loss of height, widespread bone pain with muscle weakness, or numbness around the mouth, tingling in the arms or legs, or cramps and spasms in the hands or feet, which can signal low calcium. If you take denosumab, speak with your prescriber before delaying or stopping a dose.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Pathologic Bone Demineralization is like, what's helped you, or ask the community a question.